These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9561388)

  • 1. Prophylaxis of Pneumocystis carinii pneumonia in HIV-infected children one to five years old: a multicenter surveillance study in paediatric hospitals in Germany.
    Rümmelein N; Wintergerst U; Belohradsky BH
    Infection; 1998; 26(2):135. PubMed ID: 9561388
    [No Abstract]   [Full Text] [Related]  

  • 2. Prophylaxis against Pneumocystis carinii pneumonia among children with perinatally acquired human immunodeficiency virus infection in the United States. Pneumocystis carinii Pneumonia Prophylaxis Evaluation Working Group.
    Simonds RJ; Lindegren ML; Thomas P; Hanson D; Caldwell B; Scott G; Rogers M
    N Engl J Med; 1995 Mar; 332(12):786-90. PubMed ID: 7862183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting risk of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected children.
    Rutstein RM
    Am J Dis Child; 1991 Aug; 145(8):922-4. PubMed ID: 1677526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD4 T-lymphocyte counts and Pneumocystis carinii pneumonia in pediatric HIV infection.
    Kovacs A; Frederick T; Church J; Eller A; Oxtoby M; Mascola L
    JAMA; 1991 Apr; 265(13):1698-703. PubMed ID: 1672169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1995 revised guidelines for prophylaxis against Pneumocystis carinii pneumonia for children infected with or perinatally exposed to human immunodeficiency virus. National Pediatric and Family HIV Resource Center and National Center for Infectious Diseases, Centers for Disease Control and Prevention.
    MMWR Recomm Rep; 1995 Apr; 44(RR-4):1-11. PubMed ID: 7565543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylaxis against Pneumocystis carinii pneumonia in children infected with HIV.
    Principi N; Marchisio P; Plebani A; Giaquinto C; Picco P
    Lancet; 1991 May; 337(8750):1163. PubMed ID: 1674037
    [No Abstract]   [Full Text] [Related]  

  • 7. CD4 T cell count as predictor of Pneumocystis carinii pneumonia in children born to mothers infected with HIV. European Collaborative Study Group.
    BMJ; 1994 Feb; 308(6926):437-40. PubMed ID: 7907246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benefit of primary prophylaxis before 18 months of age in reducing the incidence of Pneumocystis carinii pneumonia and early death in a cohort of 112 human immunodeficiency virus-infected infants. New York City Perinatal HIV Transmission Collaborative Study Group.
    Thea DM; Lambert G; Weedon J; Matheson PB; Abrams EJ; Bamji M; Straus WL; Thomas PA; Krasinski K; Heagarty M
    Pediatrics; 1996 Jan; 97(1):59-64. PubMed ID: 8545225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aerosolized pentamidine. Approved for HIV-infected individuals at high risk for Pneumocystis carinii pneumonia.
    Young FE; Nightingale SL; Cooper EC; Trapnell CB
    Arch Intern Med; 1989 Nov; 149(11):2412-3. PubMed ID: 2818104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Preventive pentamidine inhalation of Pneumocystis carinii pneumonia in patients with immune deficiency. Preliminary evaluation of a multicenter study].
    Schrappe-Bächer M; Fätkenheuer G; Salzberger B; Zehrer I; Bendick C; Rasokat H
    Med Klin (Munich); 1990 Apr; 85 Suppl 2():276-80. PubMed ID: 2197537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized trial of the discontinuation of primary and secondary prophylaxis against Pneumocystis carinii pneumonia after highly active antiretroviral therapy in patients with HIV infection. Grupo de Estudio del SIDA 04/98.
    Lopez Bernaldo de Quiros JC; Miro JM; Peña JM; Podzamczer D; Alberdi JC; Martínez E; Cosin J; Claramonte X; Gonzalez J; Domingo P; Casado JL; Ribera E;
    N Engl J Med; 2001 Jan; 344(3):159-67. PubMed ID: 11172138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pneumocystis carinii infections in HIV-infected children.
    Sanders-Laufer D; DeBruin W; Edelson PJ
    Pediatr Clin North Am; 1991 Feb; 38(1):69-88. PubMed ID: 1987519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discontinuation of primary prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus type I-infected patients: the changes in opportunistic prophylaxis study.
    Mussini C; Pezzotti P; Govoni A; Borghi V; Antinori A; d'Arminio Monforte A; De Luca A; Mongiardo N; Cerri MC; Chiodo F; Concia E; Bonazzi L; Moroni M; Ortona L; Esposito R; Cossarizza A; De Rienzo B
    J Infect Dis; 2000 May; 181(5):1635-42. PubMed ID: 10823763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guidelines for prophylaxis against Pneumocystis carinii pneumonia for children infected with human immunodeficiency virus.
    MMWR Recomm Rep; 1991 Mar; 40(RR-2):1-13. PubMed ID: 1672036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prospective study of primary and secondary prevention of Pneumocystis carinii pneumonia with pentamidine aerosol].
    Staszewski S; Trinder S; Gottstein A; Odewald J; Rehmet S; Brodt R; Jacobi V; Müller R; Müller H; Helm EB
    Med Klin (Munich); 1990 Apr; 85 Suppl 2():271-5. PubMed ID: 2374530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recommendations for prophylaxis against Pneumocystis carinii pneumonia.
    Veugelers PJ; Veenstra J; Coutinho RA; van Griensven GJ
    Lancet; 1993 Mar; 341(8847):758. PubMed ID: 8095654
    [No Abstract]   [Full Text] [Related]  

  • 17. Prophylaxis of Pneumocystis carinii pneumonia: too much of a good thing?
    Miller RF
    Thorax; 2000 Aug; 55 Suppl 1(Suppl 1):S15-22. PubMed ID: 10943633
    [No Abstract]   [Full Text] [Related]  

  • 18. Pneumocystis carinii pneumonia prophylaxis and early clinical manifestations of severe perinatal human immunodeficiency virus type 1 infection. Northern California Pediatric HIV Consortium.
    Maldonado YA; Araneta RG; Hersh AL
    Pediatr Infect Dis J; 1998 May; 17(5):398-402. PubMed ID: 9613653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discontinuation of secondary prophylaxis against Pneumocystis carinii pneumonia in patients with HIV infection who have a response to antiretroviral therapy. Eight European Study Groups.
    Ledergerber B; Mocroft A; Reiss P; Furrer H; Kirk O; Bickel M; Uberti-Foppa C; Pradier C; D'Arminio Monforte A; Schneider MM; Lundgren JD;
    N Engl J Med; 2001 Jan; 344(3):168-74. PubMed ID: 11188837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The prevention of Pneumocystis carinii pneumonia by pentamidine inhalation].
    Jablonowski H; Elsing C; Erckenbrecht J; Hengels KH; Strohmeyer G
    Dtsch Med Wochenschr; 1992 Jul; 117(31-32):1181-4. PubMed ID: 1353721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.